Definitive Healthcare Corp
$ 0.85
0.47%
09 Jun - close price
- Market Cap 91,036,000 USD
- Current Price $ 0.85
- High / Low $ 0.87 / 0.84
- Stock P/E N/A
- Book Value 1.39
- EPS -1.67
- Next Earning Report 2026-08-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.02 %
- ROE -0.76 %
- 52 Week High 4.70
- 52 Week Low 0.80
About
Definitive Healthcare Corp (DH) is a leading provider of data and analytics solutions specifically designed for the healthcare industry, catering to a diverse client base that includes pharmaceutical companies, payers, and healthcare providers. By harnessing extensive datasets and offering real-time analytics, the company significantly enhances operational performance and empowers its clients with strategic insights aimed at improving patient outcomes. As the demand for sophisticated healthcare analytics continues to rise amidst growing complexities in the sector, Definitive Healthcare is well-positioned to deliver innovative, data-driven solutions that facilitate operational excellence and create competitive advantages for its partners. With a strong commitment to enhancing healthcare delivery through actionable insights, DH plays a pivotal role in shaping the future of the healthcare landscape.
Analyst Target Price
$2.46
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-07 | 2026-02-26 | 2025-11-06 | 2025-08-07 | 2025-05-08 | 2025-02-27 | 2024-11-07 | 2024-08-05 | 2024-05-07 | 2024-02-28 | 2023-11-02 | 2023-08-14 |
| Reported EPS | 0.06 | 0.06 | 0.07 | 0.07 | 0.05 | 0.08 | 0.1 | 0.09 | 0.08 | 0.07 | 0.09 | 0.08 |
| Estimated EPS | 0.03 | 0.061 | 0.06 | 0.05 | 0.02 | 0.0718 | 0.08 | 0.09 | 0.08 | 0.08 | 0.06 | 0.06 |
| Surprise | 0.03 | -0.001 | 0.01 | 0.02 | 0.03 | 0.0082 | 0.02 | 0 | 0 | -0.01 | 0.03 | 0.02 |
| Surprise Percentage | 100% | -1.6393% | 16.6667% | 40% | 150% | 11.4206% | 25% | 0% | 0% | -12.5% | 50% | 33.3333% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-06 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.04 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: DH
2026-06-09 13:39:35
Definitive Healthcare director Samuel A. Hamood was granted 189,190 restricted stock units (RSUs) of Class A Common Stock at no cash cost. These RSUs are set to vest on the earlier of June 4, 2027, or the company's next annual stockholder meeting, contingent on his continued service. Following this grant, Hamood directly holds 289,396 Class A shares and indirectly holds an additional 51,582 shares through AMHAM DH LLC.
2026-06-08 23:09:41
Definitive Healthcare (DH) director Scott G. Stephenson was granted 189,190 restricted stock units (RSUs) of Class A Common Stock. These RSUs will vest on the earlier of June 4, 2027, or the company's next annual stockholder meeting, conditional on his continued service. Following this grant, Stephenson directly holds 313,314 shares of Class A Common Stock.
2026-06-08 21:09:41
Definitive Healthcare Corp. (DH) reported that its director, Kathleen A. Winters, was granted 189,190 restricted stock units (RSUs) of Class A Common Stock. This equity grant, with no purchase price, increases her direct holdings to 308,982 shares. The RSUs are set to vest on the earlier of June 4, 2027, or the company’s next annual stockholders’ meeting, provided she continues her service.
2026-06-08 20:09:41
Definitive Healthcare Corp. director Chilukuri Sastry was granted 189,190 restricted stock units (RSUs) on June 4, 2026, increasing his direct holdings to 315,984 shares. These RSUs are a compensation award with no purchase price and will vest on the earlier of June 4, 2027, or the company's next annual meeting, provided Sastry continues his service. This transaction was reported in a Form 4 filing, detailing the award and its vesting conditions.
2026-06-05 20:09:44
Definitive Healthcare Corp. shareholders approved all proposals at their 2026 annual meeting, including the election of three Class II directors, the ratification of Deloitte & Touche LLP as independent auditor, and an increase of 15,000,000 shares to the 2021 Equity Incentive Plan. They also gave non-binding advisory approval to the compensation of named executive officers. These decisions reflect broad investor support for the company's governance and compensation strategies.
2026-06-03 20:10:07
Definitive Healthcare (DH) CEO Kevin Coop had 66,050 shares of Class A Common Stock withheld at $0.99 per share to cover tax obligations related to the vesting of restricted stock units (RSUs). This transaction was a tax disposition, not an open-market sale, and represents a small portion of his total holdings of 5,012,822 Class A shares. The filing indicates a compensation-related event rather than a discretionary stock sale by the CEO.
